Presentation is loading. Please wait.

Presentation is loading. Please wait.

Trusted evidence. Informed decisions. Better health. The Cochrane Tobacco Addiction Group at 20: ensuring our evidence is relevant Dr Nicola Lindson-Hawley.

Similar presentations


Presentation on theme: "Trusted evidence. Informed decisions. Better health. The Cochrane Tobacco Addiction Group at 20: ensuring our evidence is relevant Dr Nicola Lindson-Hawley."— Presentation transcript:

1 Trusted evidence. Informed decisions. Better health. The Cochrane Tobacco Addiction Group at 20: ensuring our evidence is relevant Dr Nicola Lindson-Hawley Managing Editor Cochrane Tobacco Addiction Group Nuffield Department of Primary Care Health Sciences, University of Oxford @cochraneTAG Evidence Live 2016: Thursday 23 rd June

2  One of 53 topic specific, Cochrane Review Groups  Based in Nuffield Department of Primary Care, University of Oxford  Carry out and manage high quality systematic reviews of interventions for tobacco use & prevention  7 editorial staff; over 90 reviews, 350 authors  Not-for-profit- National Institute for Health Research (NIHR) funded  Established 1996. 2016 is our 20 th anniversary! Cochrane Tobacco Addiction Group (CTAG)

3 The Cochrane TAG 20 th anniversary priority setting project (CTAG taps)  Developed by members of CTAG and department communications manager  Funded by the NIHR School for Primary Care Research AIMS 1.Raise awareness of the group, and what we have achieved so far 2.Identify areas where further research is needed in the areas of tobacco control & smoking cessation by involving our stakeholders 3.Identify specific goals for Cochrane TAG

4 Involving our stakeholders  Until now CTAGs work has mainly been informed by researchers  Including others in decisions about future directions will enable findings to: 1) be better applied to those who need them; and 2) have a higher global impact  Inspired by the work of the James Lind Alliance  Some of CTAG’s stakeholders: Policy makers Research funders Researchers Healthcare providers Current & former smokers Healthcare commissioners

5 Methods  Developed survey asking respondents to share a max. of 4 questions they would like to see answered by tobacco control research in general  Aimed at anyone with an interest in tobacco (personal or professional)  Presented to Nottingham smoker’s panel – adjusted in response to comments  Built in Survey Monkey and accessed via internet link  Disseminated link via mailing lists, contacting public health organisations, Twitter, Facebook, conferences, blogging Survey stage 1: Identifying uncertainties

6 Survey stage 1: Identifying uncertainties Results  Removed duplicates from submitted questions leaving 258  15 were non-empirical questions  60 already answered - more effective dissemination needed?  183 unanswered questions identified  All these decisions were made by at least 2 people independently What smoking quit rates do Quitlines result in? What are the health effects of waterpipe use?

7 Research categories Addressing inequalitiesNicotine and tobacco risk Alternative tobacco productsPopulation level interventions Digital interventionsPregnancy E-cigarettesSmoking bans and second-hand smoke Illness & chronic disease sufferersSmoking treatment methods excluding medications Initiating quit attemptsTreatment delivery MedicationsYoung people Mental health and other substance abuse  Our uncertainties were classified into 15 research categories, containing 3-21 questions each

8 Methods  Survey developed asking respondents to: 1.rank the 15 research categories identified in Stage 1 in order of importance (prioritisation): 1= most important; 15= least important 2.Rank the questions within their top 3 categories (1=most important)  Again, checked by member of the public, built in Survey Monkey, accessed via internet link  Sent out via email to the 278 stage 1 respondents who provided contact details  Opportunity to win 1 of 3 Amazon vouchers Survey stage 2: Ranking uncertainties

9  175 people completed the survey (63% of those invited)  Total ranks for each category/question were added together. Total scores were ordered within their set and given an overall rank

10  Built on survey findings but focused more specifically on prioritisation for Cochrane TAG  Practical workshop session designed and led by independent facilitation company- Hopkin van Mil  Where CTAG should focus its future efforts and ways to disseminate findings Stage 3: Prioritisation Workshop

11 Setting the scene

12 Prioritising CTAG research & dissemination

13  Analyse workshop data: flip charts, audio recordings, delegate notes  Write-up as a report for publication in a scientific journal  Present the results at international conferences  Use findings to set CTAG priorities and begin working on these by the end of 2016  Develop new review dissemination plan Next steps

14 How to find out more or contact us  Visit our website: http://tobacco.cochrane.org/  Tweet us: @cochraneTAG  Email us: nicola.lindson-hawley@phc.ox.ac.uk  Call us: +44 (0)1865 289 320 National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a partnership between the Universities of Bristol, Cambridge, Keele, Manchester, Newcastle, Nottingham, Oxford, Southampton and University College London. This presentation summarises independent research funded by the National Institute for Health Research School for Primary Care Research. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.


Download ppt "Trusted evidence. Informed decisions. Better health. The Cochrane Tobacco Addiction Group at 20: ensuring our evidence is relevant Dr Nicola Lindson-Hawley."

Similar presentations


Ads by Google